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ABSTRACT
Undifferentiated carcinoma of the head and neck is frequently observed in 
nasopharynx, however it may also occur in oropharynx, salivary gland and 
sinonasal. Overlapping lesions in those regionscreate difficulty in determining 
the origin of the tumor. Thus, it causes diagnostic pitfall not only for pathologists, 
but also for clinicians. A 40 yearold man, presented with nasal obstruction, 
epistaxis, diplopia, and headache for a yearand showed nasal cavitysinistra 
and nasopharynx masses on CT-scan. Lymph node enlargement was not 
detected. First biopsywas performed and histopathologically diagnosed as 
nasopharyngeal undifferentiated carcinoma(NPC), extended into nasal cavity. 
Chemo-radiation protocol for NPC was conducted, and showing uncomplete 
response. Second biopsy was done, and reviewed with the first biopsy result. 
Thetumourwas arranged insolid, syncytial and trabecular pattern, with 
vesicular nuclei, prominent nucleoli, and lack of lymphoplasmacytic infiltrat. 
Immunohistochemistry (IHC) analysis of p16, EBNA1 and LMP1 were negative. 
PCR analysis of HPV-18 was positive, while EBV detection showed negative 
result. General association of EBV with NPC suggests that the presence of 
latent EBV infection can serve as a positive marker for NPC. Therefore, in this 
case, the EBV negativity and strong HPV association led to diagnosis of SNUC. 
The distinction of sinonasal undifferentiated carcinoma (SNUC) or from NPC 
was important for appropriate management and therapy.
ABSTRAK
Undifferentiated carcinoma pada regio kepala dan leher biasanya terjadi 
pada daerah nasofaring, tetapi juga bisa terjadipada daerah orofaring, 
kelenjar liur dan sinonasal. Lesi-lesi yang muncul pada daerah ini sering 
tumpang tindih dan menyebabkan kesulitan penetapan asal tumor, serta 
menimbulkan kesalahan diagnosis tidak saja bagi ahli patologi, tetapi juga 
bagi ahli bedah. Seorang laki-laki berusia 40 tahun dengan keluhan hidung 
tersumbat, epistaksis, diplopia, dan nyeri kepala selama 1 tahun. CT-Scan 
menunjukkan massa pada kavum nasi kiri dan massa pada nasofaring. 
Tidak didapatkan pembesaran limfonodi. Dilakukan biopsi pada massa 
kavum nasi kiri, dan didiagnosis secara histopatologi sebagai nasopharyngeal 
undifferentiated carcinoma (NPC) yang meluas ke kavum nasi. Dilakukan 
radiasi dan kemoterapi untuk NPC, dan menunjukkan respon yang kurang 
sempurna. Kemudian dilakukan biopsi yang kedua, dan direview dengan 
biopsi yang pertama. Gambaran histopatologi menunjukkan tumor epitelial 
yang tersusun solid, sinsisial, dan trabekuler, dengan inti vesikuler, dan anak 
inti prominent, dengan sebukan sedikit limfosit. Pengecatan imunohistokimia 
dengan p16, EBNA1 dan LMP1 menunjukkan hasil negatif. Analisa PCR 
mendeteksi adanya HPV tipe 18, sedangkan PCR untuk EBV menunjukkan 
hasil negatif. Dapatdisimpulkan, hubungan yang erat antara EBV dengan NPC 
dapat digunakan sebagai penanda bahwa infeksi latent EBV menunjukkan 
keberadaan karsinoma nasofaring. Sehingga tidak adanya hubungan dengan 
EBV dan adanya hubungan dengan HPV pada kasus ini mengarahkan 
diagnosis pada sinonasal undifferentiated carcinoma (SNUC). Membedakan 
NPC dan SNUC sangat penting untuk manajemen dan terapi yang optimal.
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INTRODUCTION
Undifferentiated carcinoma of the 
head and neck mostlyoccurredin the 
nasopharynx.1 However, tumors with 
identical morphological features can 
also occur in oropharynx, salivary 
gland and sinonasal.2–4 Undifferentiated 
carcinoma in the sinonasal tract may 
occur as primary lession (sinonasal 
undifferentiated carcinoma / SNUC) 
or extention from a destructive 
undifferentiated nasopharyngeal 
carcinoma (NPC).5,6 Palomba A & Cardesa 
A (2011 Overlapping lesions in these 
region and similarity in morphology 
producedifficulty in determining 
definitive diagnosis of the tumor, and 
often bring diagnostic pitfall not only 
for pathologists, but also for clinicians. 
The difference of SNUC and NPC has 
traditionally rested on histopathology 
finding, however the association of EBV 
with NPC suggests that the presence of 
latent EBV infection serve as a marker to 
discernthose tumors.5,6 
SNUC usually presents as large 
necrotic exophytic massesinvolving 
multiple sites in sinonasal tract and 
may extend into the nasopharynx. The 
tumor is invasive, with common orbital 
and cranial infiltration.7 this complex 
anatomic region may represent the site of 
aggressive, non-squamous cell epithelial 
and nonepithelial malignant neoplasms 
of varying histogenesis, which are 
grouped under the term undifferentiated 
malignant neoplasms. Frequently, these 
undifferentiated malignancies share 
clinical and light microscopic features, 
which makes differentiation of one 
from the other virtually impossible 
without the use of adjunct analyses 
(eg, immunohistochemistry, electron 
microscopy, or molecular biologic studies 
SNUC harbors high-risk association 
with HPV DNA (types 16 and 18) virus 
infection.8 Its immunohistochemical 
staining profile has been incompletely 
characterized, and little work has been 
done on its expression of the markers 
for human papillomavirus (HPV In 
contrast to NPC, an association with 
Epstein-Barr virus infection has not 
been clearly demonstrated.6,9 SNUC 
have been incompletely characterized 
immunohistochemically, and their 
undifferentiated appearance often 
requires such ancillary studies to aid in 
their distinction from other high-grade 
neoplasms. To address these two issues, 
25 cases of SNUC diagnosed between the 
years 1983 and 1999 were selected from 
our files. EBER in situ hybridization (ISH 
Morphologically, SNUC arecomposed 
of nests cells with a delicate fibrous 
background, distinct cellular borders, 
coarse cromatin, prominent nucleoli, 
brisk mitotic, extensive necrosis, and 
scant lymphoplasmacytic infiltrat.5,6,10 
SNUC have been incompletely 
characterized immunohistochemically, 
and their undifferentiated appearance 
often requires such ancillary studies 
to aid in their distinction from other 
high-grade neoplasms. To address 
these two issues, 25 cases of SNUC 
diagnosed between the years 1983 
and 1999 were selected from our files. 
EBER in situ hybridization (ISH There 
is no optimal management guidelines 
proved to be succesful in treating this 
tumor.11 Combined radical resection, 
radiotherapy and chemotherapy have 
evolved to the current recommendation 
treatment regimens.12
NPC presentswith one or more 
of 4 groups of symptoms; including 
nasal symptoms (epistaxis), nasal 
obstruction and discharge; otologic 
symptoms(deafness and tinnitus); 
cranial nerve palsies (commonly 5th and 
6th cranial nerves); and neck masses 
(usually appear in the upper neck).13 
EBV plays a role in the development of 
NPC.6,14,15 Histopathologically, NPC are 
composed of syncytial cells aggregates 
with indistinct cellular borders, vesicular 
cromatin, inconspicuous nucleoli, 
variable mitotic, infrequent necrosis, and 
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usually with a lot of lymphoplasmacytic 
infiltrat.5,6,10  NPC has a better prognosis 
and more responsive to radiation 
therapy than SNUC.5 The distinction of 
undifferentiated carcinoma from the 
nasal cavity (SNUC) or the nasopharynx 
(NPC) is important for appropriate 
management and therapy.5
CASE 
A 40 year old man, present with 
nasal obstruction, epistaxis, diplopia, 
and headache for a year before 
admitted to Dr.Sardjito General 
Hospital, Yogyakarta, Indonesia. CT Scan 
showed right nasopharynx mass, with 
infiltration to surrounding tissue and 
infiltrated to intracranial. Biopsy from 
ear and nasal cavity was performed in 
other hospital, and histopathologically 
diagnosed as undifferentiated 
carcinoma, with possible extention 
from nasopharynx. Chemo-radiation 
protocol for NPC was conducted. The 
patient recieved cysplatin 100 mg/m2 
for the first day, and 5-fluorouracil 1000 
mg/m2 for the first until the fourth day, 
in 28 day cycle, for 4 cycle, continued 
with secondline chemotherapy regimen 
for 4 cycle. The patient also received 31 
cycle radiotherapy. Six months following 
completion of treatment, the tumor 
showed uncomplete response, and 
repeat imaging wasperformed as shown 
in FIGURE 1.
FIGURE 1. Head and neck MSCT scan after complete chemo-radiotherapy. The 
analysis result showed inhomogen mass in the left nasal cavity, 
left nasopharynx, left maxillary sinus and infiltrated into left fossa 
temporalis.
 
The second biopsy was performedin 
Dr.Sardjito General Hospital, Yogyakarta, 
Indonesia, and reviewed with the first 
biopsy result. Macroscopic features 
showed fragmented tissue from nasal 
cavity sinistra, 0.8 cc, tan to white and 
rubbery in consistency, mean while 
sample from the nasopharynx was 0.5 cc, 
tan to white in colour and also rubbery. 
Microscopically, nasal cavity specimens 
showed tumour nests arranged insolid, 
and trabecular pattern, with vesicular 
nuclei and prominent nucleoli. The 
background showed desmoplastic 
stroma with scant lymphoplasmacytic 
infiltrat, without prominent necrosis 
(FIGURE 2). There was no tumor in the 
nasopharynx specimen. IHC analysis was 
performed, usingp16, EBNA1 and LMP1 
(Abcam and Novocastra) antibodies. 
The staining revealednegative result as 
shown in FIGURE 3. 
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FIGURE 2. Microscopic features of sinonasal specimen.Tumor composed of solid, 
syncytial and tubercular nests. The cells were pleomorphic, with indistinct 
borders, vesicular nuclei, and prominent nuclei. The background was 
desmoplastic stroma with scanty lymphoplasmatic infiltrate (HE, 40, 
200x, 400x).
FIGURE 3. Immunohistochemistrry result. Staining for p16, EBNA1, LMP1 showed 
neative result (100x)
 
PCR analysis of HPV and EBV were 
then performed. DNA was extracted 
from formaline-fixed paraffin-
embedded (FFPE) tissue specimens. DNA 
amplification for HPV was performed 
with AB Analitica Ampliquality HPV-
TYPE Express v3.0, and continued with 
genotyping with reverse line blot. The 
test revealed HPV-18 positive as shown 
in FIGURE4. 
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FIGURE 4. DNA amplification of HPV. 
The genotyping used reverse 
line blot, showed positive 
result for HPV-18.
DNA amplification for EBV was 
using two primers that target EBV1_F: 5’ 
– AAGGAGGGTGGTTTGGAAAG – 3’, and 
EBV1_R: 5’ – AGACAATGGACTCCCTTAGC 
– 3’. Gel electrophoresis showed negative 
result for EBV (FIGURE5).
 
Line 1 Line 2 
600 bp 
FIGURE 5. DNA amplification 
of EBV. Line 2 : DNA 
amplification for EBV and 
gel electrophoresis showed 
negative result. Line 1: 
Positive control
DISCUSSION
SNUC isa rare malignancy and 
firstly described by Frierson et al.16 It 
wasoriginally defined as a high-grade 
malignant epithelial neoplasm of the 
nasal cavity and paranasal sinuses of 
uncertain histogenesis with or without 
neuroendocrine differentiation, but 
without evidence of squamous or 
glandular differentiation. Furthermore, 
World Health Organization classification 
redefined SNUC as a highly aggressive 
and clinicopathologically distinctive 
carcinoma of uncertain histogenesis that 
typically presents with locally extensive 
disease. Although the exact histogenesis 
are unknown, it has been believed that 
SNUC was originate from schneiderian 
epithelium or from the nasal ectoderm 
of the paranasal sinuses.7,16
The etiology of SNUC is unknown. 
Some cases have occured after prior 
radiation therapy for nasopharyngeal 
carcinoma.17 Association of 
EBV with SNUC have shown 
controversial result.6 SNUC have 
been incompletely characterized 
immunohistochemically, and their 
undifferentiated appearance often 
requires such ancillary studies to 
aid in their distinction from other 
high-grade neoplasms. To address 
these two issues, 25 cases of SNUC 
diagnosed between the years 1983 
and 1999 were selected from our 
files. EBER in situ hybridization (ISH 
However, a significant subset of 
SNUC (7 of 11) was associated with 
EBV, where as all Western cases were 
negative for EBV. The Asian SNUC that 
showed EBV positivity were limited 
to those showing similar features 
to anaplastic large cell lymphoma, 
or mimicking undifferentiated 
nasopharyngeal carcinoma.6,18 
The latter were then referredto 
primary sinonasal nasopharyngeal-
type undifferentiated carcinoma 
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(lymphoepithelioma).6,19
Sinonasalcarcinoma, including 
SNUC, harbor high-risk  HPV DNA 
(types 16 and 18) virus infection.20 
Several studies have confirmed its 
causal role in a subgroup of upper 
aerodigestive tract tumours. Of 
the non-genital cancers, tonsillar 
carcinomas (TCs Recent study 
reported that HPV-positive cancers 
ofthe head and neck, including the 
tonsil, oropharynx, and oral cavity 
hada better overall survivalthan HPV-
negative cancers.21 Although the exact 
mechanism is not fully understood, 
three possible explanations could be 
a) the genome of HPV positive cancer 
cells is less unstable and/or, b) HPV-
positive cells suffer from hypoxia 
and can be more easily induced to 
apoptosis or, c) treatment improves 
the local immunity favouring the 
eradication of HPV (and regression of 
the tumour).21,22
HPV status is also associated with 
p16 expression, and HPV-positive 
tumours are less likely to harbour 
p53 mutations.21–24 Rb inactivation 
by the viral oncoprotein E7 induces 
overexpression of p16, therefore 
immunohistochemical detection of p16 
serves as a surrogate marker for high 
risk HPV in oropharyngeal cancers.25 The 
HPV viral E6 protein can cause a p53 gene 
mutation that inactivates p53 protein and 
interferes with p53 function by targeting 
it for ubiquitination and degradation.26 
However, in this case, IHC staining for 
p16 was failed to demonstrated the 
correlation of HPV with the tumor.
Therefore  PCR analysis was performed 
and proved the involvementof HPV 
infection.
The HPV testing methods are mostly 
based on detecting HPV DNA in cancer 
tissues either with in situ hybridization 
(ISH) or PCR or both. With regard to the 
detection method, PCR-based studies 
reported a higher prevalence rate than 
ISH-based rates, especially in the oral 
cancer subgroup.27
CONCLUSION
The universal association of EBV 
with NPC suggests that the presence of 
latent EBV infection serve as a marker 
to distinguish NPC from SNUC. SNUC are 
typically negative for EBV and positive 
for HPV. The distinction of SNUC or NPC is 
important forappropriate management 
and therapy.
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